Tissue engineering of heart valves: PEGylation of decellularized porcine aortic valve as a scaffold for in vitro recellularization

BioMedical Engineering Online

Volumn 12, Issue 1, 2013, Pages

  Zhou, Jianliang ^a   Hu, Shidong ^a   Ding, Jingli ^a   Xu, Jianjun ^a   Shi, Jiawei ^b   Dong, Nianguo ^b  

^a NANCHANG UNIVERSITY   (China)

^b UNION HOSPITAL   (China)

Author keywords

Decellularized valves; GRGDSPC peptides; Michael addition reaction; Polyethylene glycol; VEGF165

Indexed keywords

ADDITION REACTIONS; ENDOTHELIAL CELLS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; POLYETHYLENE OXIDES; PROPYLENE; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY; TENSILE STRENGTH; TENSILE TESTING;

DECELLULARIZED; GRAFT CO POLYMERIZATIONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; MICHAEL ADDITION REACTIONS; TISSUE ENGINEERING APPLICATIONS; TISSUE-ENGINEERED HEART; VASCULAR ENDOTHELIAL GROWTH; VEGF165;

POLYETHYLENE GLYCOLS;

5 HYDROXYL MONO METHYL ISOPHTHALATE; ACRYLOYL CHLORIDE; CROSS LINKING REAGENT; DICHLOROMETHANE; EOSIN; GRGDSPC PEPTIDE; HEMATOXYLIN; HEPTAPEPTIDE; LITHIUM ALUMINIUM TETRAHYDRIDE; LITHIUM DERIVATIVE; MACROGOL 20000; METHANESULFONYL CHLORIDE; MONOMER; PHTHALIC ACID DERIVATIVE; PROPYLENE; RECOMBINANT VASCULOTROPIN; SULFONIC ACID DERIVATIVE; THIOL GROUP; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN 165; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; IMMOBILIZED PROTEIN; MACROGOL DERIVATIVE; OLIGOPEPTIDE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL DEGENERATION; CELL GROWTH; CELL REGENERATION; CELL SPREADING; CONJUGATION; CONTROLLED STUDY; CROSS LINKING; DECELLULARIZED PORCINE AORTIC VALVE; DNA CONTENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; LIMIT OF QUANTITATION; MICHAEL ADDITION; NONHUMAN; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; SWINE; SYNTHESIS; TENSILE STRENGTH; TISSUE CHARACTERIZATION; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; MATERIALS TESTING; MECHANICS; METABOLISM;

SUS;

ANIMALS; AORTIC VALVE; CELL PROLIFERATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMOBILIZED PROTEINS; MATERIALS TESTING; MECHANICAL PROCESSES; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884394611     PISSN: None     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-12-87     Document Type: Article

References (39)

1. Dong X, Wei X, Yi W, Gu C, Kang X, Liu Y, Li Q, Yi D. RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering. J Mater Sci-Mater M 2009, 20:2327-2336.
2. Filova E, Straka F, Mirejovský T, Mašín J, Bačáková L. Tissue-engineered heart valves. Physiol Res 2009, 58:S141-S158.
3. Dohmen PM. Clinical results of implanted tissue engineered heart valves. HSR Proceedings In Intensive Care & Cardiovascular Anesthesia 2012, 4:225-231.
4. Dijkman PE, Driessen-Mol A, Frese L, Hoerstrup SP, Baaijens FP. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials 2012, 33:4545-4554. 10.1016/j.biomaterials.2012.03.015, 22465337.
5. Simionescu DT, Chen J, Jaeggli M, Wang B, Liao J. Form follows function: advances in trilayered structure replication for aortic heart valve tissue engineering. J Healthcare Engineering 2012, 3:179-202.
6. Wu S, Liu YL, Cui B, Qu XH, Chen GQ. Study on decellularized porcine aortic valve/poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) hybrid heart valve in sheep model. Artif Organs 2007, 31:689-697. 10.1111/j.1525-1594.2007.00442.x, 17725696.
7. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardio-Thorac 1998, 14:279-284.
8. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 2002, 11:457-462.
9. Schenke-Layland K, Vasilevski O, Opitz F, Konig K, Riemann I, Halbhuber KJ, Wahlers T, Stock UA. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003, 143:201-208. 10.1016/j.jsb.2003.08.002, 14572475.
10. Zhai W, Chang J, Lin K, Wang J, Zhao Q, Sun X. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Biomaterials 2006, 27:3684-3690.
11. Ye XF, Hu X, Wang HZ, Liu J, Zhao Q. Polyelectrolyte multilayer film on decellularized porcine aortic valve can reduce the adhesion of blood cells without affecting the growth of human circulating progenitor cells. Acta Biomater 2012, 8:1057-1067. 10.1016/j.actbio.2011.11.011, 22122977.
12. Zhou J, Fritze O, Schleicher M, Wendel HP, Schenke-Layland K, Harasztosi C, Hu S, Stock UA. Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity. Biomaterials 2010, 31:2549-2554. 10.1016/j.biomaterials.2009.11.088, 20061016.
13. Liao J, Joyce EM, Sacks MS. Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials 2008, 29:1065-1074. 10.1016/j.biomaterials.2007.11.007, 2253688, 18096223.
14. Mendoza-Novelo B, Avila EE, Cauich-Rodriguez JV, Jorge-Herrero E, Rojo FJ, Guinea GV, Mata-Mata JL. Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content. Acta biomater 2011, 7:1241-1248. 10.1016/j.actbio.2010.11.017, 21094703.
15. Tudorache I, Cebotari S, Sturz G, Kirsch L, Hurschler C, Hilfiker A, Haverich A, Lichtenberg A. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves. J Heart Valve Dis 2007, 16:567-573. discussion 574.
16. Somers P, De Somer F, Cornelissen M, Thierens H, Van Nooten G. Decellularization of heart valve matrices: search for the ideal balance. Artif Cells Blood Substit Immobil Biotechnol 2012, 40:151-162. 10.3109/10731199.2011.637925, 22192069.
17. Vismara R, Soncini M, Talo G, Dainese L, Guarino A, Redaelli A, Fiore GB. A bioreactor with compliance monitoring for heart valve grafts. Ann Biomed Eng 2010, 38:100-108. 10.1007/s10439-009-9803-1, 19784774.
18. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000, 102:III50-III55.
19. Grauss RW, Hazekamp MG, Oppenhuizen F, van Munsteren CJ, Gittenberger-de Groot AC, De Ruiter MC. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur J Cardio-Thorac 2005, 27:566-571.
20. Shi J, Dong N, Sun Z. Immobilization of decellularized valve scaffolds with Arg-Gly-Asp-containing peptide to promote myofibroblast adhesion. J Huazhong Univ Sci 2009, 29:503-507.
21. Yang M, Chen CZ, Shu YS, Shi WP, Cheng SF, Gu YJ. Preseeding of human vascular cells in decellularized bovine pericardium scaffold for tissue-engineered heart valve: an in vitro and in vivo feasibility study. J Biomed Mater Res B 2012, 100:1654-1661.
22. Chen JS, Noah EM, Pallua N, Steffens GC. The use of bifunctional polyethyleneglycol derivatives for coupling of proteins to and cross-linking of collagen matrices. J Mater Sci-Mater M 2002, 13:1029-1035.
23. Riener CK, Kada G, Gruber HJ. Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4'-dithiodipyridine. Anal Bioanal Chem 2002, 373:266-276. 10.1007/s00216-002-1347-2, 12110978.
24. Christmann A, Ienny P, Quantin J, Caro-Bretelle A, Lopez-Cuesta J. Mechanical behaviour at large strain of polycarbonate nanocomposites during uniaxial tensile test. Polymer 2011, 52:4033-4044.
25. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2007, 2:481-485.
26. Jain N, Nahar M. PEGylated nanocarriers for systemic delivery. Methods Mol Biol 2010, 624:221-234. 10.1007/978-1-60761-609-2_15, 20217599.
27. Joralemon MJ, McRae S, Emrick T. PEGylated polymers for medicine: from conjugation to self-assembled systems. Chem Commun (Camb) 2010, 46:1377-1393.
28. Ingavle GC, Dormer NH, Gehrke SH, Detamore MS. Using chondroitin sulfate to improve the viability and biosynthesis of chondrocytes encapsulated in interpenetrating network (IPN) hydrogels of agarose and poly(ethylene glycol) diacrylate. J Mater Sci-Mater M 2012, 23:157-170.
29. Davidovich-Pinhas M, Bianco-Peled H. Novel mucoadhesive system based on sulfhydryl-acrylate interactions. J Mater Sci-Mater M 2010, 21:2027-2034.
30. Porter AM, Klinge CM, Gobin AS. Biomimetic hydrogels with VEGF induce angiogenic processes in both hUVEC and hMEC. Biomacromolecules 2011, 12:242-246. 10.1021/bm101220b, 21128597.
31. Jevševar S, Kunstelj M, Porekar VG. PEGylation of therapeutic proteins. J Biotechnol 2010, 5:113-128.
32. Zhu J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 2010, 31:4639-4656. 10.1016/j.biomaterials.2010.02.044, 2907908, 20303169.
33. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl 2010, 49:6288-6308. 10.1002/anie.200902672, 20648499.
34. Vanderhooft JL, Mann BK, Prestwich GD. Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials. Biomacromolecules 2007, 8:2883-2889. 10.1021/bm0703564, 17691843.
35. Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 1977, 252:3578-3581.
36. Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977, 252:3582-3586.
37. Dingels C, Wurm F, Wagner M, Klok HA, Frey H. Squaric acid mediated chemoselective pegylation of proteins: reactivity of single-step-activated alpha-amino poly(ethylene glycol)s. Chemistry 2012, 18:16828-16835. 10.1002/chem.201200182, 23135990.
38. Banerjee SS, Aher N, Patil R, Khandare J. Poly(ethylene glycol)-prodrug conjugates: concept, design, and applications. J Drug Del 2012, 2012:103973.
39. Roberts M, Bentley M, Harris J. Chemistry for peptide and protein PEGylation. Adv Drug Deliver Rev 2012, 64(supplement):116-127.